FHS Unternehmensberatung and Recipharm Pharmaceutical Development AB have entered a collaboration under which FHS will market and sell Recipharm’s development services, including formulation development, analytical development, manufacture of clinical trial material and stability studies, to customers in Austria, Germany and Switzerland. 
 
“I am very excited about this collaboration,” said Torkel Gren, sales director, Recipharm. “FHS Unternehmensberatung has through its owner Fritz H. Speck an excellent knowledge of the contract development business and a very valuable network in German speaking countries. I am convinced that this will help us to reach out to new customers”.
 
“I am deeply impressed by the capabilities, the excellent experience and the staff’s extraordinary team spirit at Recipharm PD,” said Fritz Speck, owner of FHS. “To me it seems quite clear, that especially clients in the German-speaking market could benefit a lot from the attractive opportunities and multilingual experience at Recipharm PD. I look forward to a successful and pleasant cooperation with the team.”